PMHS (Polomar Health Services) Return-on-Tangible-Equity: 0.00% (As of Mar. 2026)


PMHS Polomar Health Services Inc PMHS
34 GF Score
Price $0.12
GF Value $12.38
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Polomar Health Services Return-on-Tangible-Equity?

Polomar Health Services PMHS 34 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates PMHS with a GF Score™ of 34/100 and a GF Value™ of $12.38 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 171821.13% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Polomar Health Services's annualized net income for the quarter that ended in Mar. 2026 was $-0.10 Mil. Polomar Health Services's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-1.23 Mil. Therefore, Polomar Health Services's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Polomar Health Services's Return-on-Tangible-Equity or its related term are showing as below:

PMHS's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.065
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Polomar Health Services  (OTCPK:PMHS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Polomar Health Services Return-on-Tangible-Equity Related Terms


Polomar Health Services Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Polomar Health Services's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polomar Health Services Return-on-Tangible-Equity Chart

Polomar Health Services Annual Data
Trend Dec07 Dec08 Dec09 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial -363.64 -185.64 -852.17 0.00 0.00

Polomar Health Services Quarterly Data
Dec09 Mar10 Jun10 Sep10 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PMHS vs DHTI, RDGT, BLMH: Return-on-Tangible-Equity Comparison

For the Pharmaceutical Retailers subindustry, Polomar Health Services's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polomar Health Services Return-on-Tangible-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Polomar Health Services's Return-on-Tangible-Equity falls into.


PMHS
34GF Score
Polomar Health Services Inc PMHS
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polomar Health Services Return-on-Tangible-Equity Calculation

Polomar Health Services's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-10.701/( (-1.136+-1.222 )/ 2 )
=-10.701/-1.179
=N/A %

Polomar Health Services's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-0.1/( (-1.222+-1.246)/ 2 )
=-0.1/-1.234
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Polomar Health Services (PMHS) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #999999 out of 582 companies in the Healthcare Providers & Services industry.
Is Polomar Health Services' Return-on-Tangible-Equity too high?
Polomar Health Services' current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Polomar Health Services ranks #999999 out of 582 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Polomar Health Services has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' Return-on-Tangible-Equity compare to DHTI and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #999999 out of 582 companies for Return-on-Tangible-Equity. This places Polomar Health Services in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $12.38, compared to a current price of $0.12 — trading 99% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Polomar Health Services' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polomar Health Services (PMHS) Overvalued in 2026?

Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued. The current stock price of $0.12 is trading 99% below its estimated GF Value™ of $12.38. GuruFocus considers Polomar Health Services to be Possible Value Trap.

Key valuation signals for PMHS:

  • Return-on-Tangible-Equity: 0.00%
  • GF Value™: $12.38 vs. price of $0.12 (99% below fair value)
  • GF Score™: 34/100 with 4 warning signs

No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Polomar Health Services Business Description

Address 32866 US Highway, 19 N, Los Angeles, FL, USA, 34684
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
34GF Score

Get the complete analysis for PMHS

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price
$12.38
GF Value